3odk
From Proteopedia
(Difference between revisions)
m (Protected "3odk" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | + | ==Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution== | |
| - | + | <StructureSection load='3odk' size='340' side='right' caption='[[3odk]], [[Resolution|resolution]] 2.30Å' scene=''> | |
| - | {{ | + | == Structural highlights == |
| + | <table><tr><td colspan='2'>[[3odk]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3ODK OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3ODK FirstGlance]. <br> | ||
| + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ODK:3-PYRIDIN-2-YL-1H-PYRAZOLE-5-CARBOXYLIC+ACID'>ODK</scene>, <scene name='pdbligand=PE4:2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL'>PE4</scene></td></tr> | ||
| + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3kab|3kab]], [[3kac|3kac]], [[3kad|3kad]], [[3kaf|3kaf]], [[3kag|3kag]], [[3kah|3kah]], [[3kai|3kai]], [[3kce|3kce]]</td></tr> | ||
| + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">PIN1 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])</td></tr> | ||
| + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Peptidylprolyl_isomerase Peptidylprolyl isomerase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=5.2.1.8 5.2.1.8] </span></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3odk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3odk OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3odk RCSB], [http://www.ebi.ac.uk/pdbsum/3odk PDBsum]</span></td></tr> | ||
| + | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Pin1 is an emerging oncology target strongly implicated in Ras and ErbB2-mediated tumourigenesis. Pin1 isomerizes bonds linking phospho-serine/threonine moieties to proline enabling it to play a key role in proline-directed kinase signalling. Here we report a novel series of Pin1 inhibitors based on a phenyl imidazole acid core that contains sub-muM inhibitors. Compounds have been identified that block prostate cancer cell growth under conditions where Pin1 is essential. | ||
| - | + | Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution.,Potter A, Oldfield V, Nunns C, Fromont C, Ray S, Northfield CJ, Bryant CJ, Scrace SF, Robinson D, Matossova N, Baker L, Dokurno P, Surgenor AE, Davis B, Richardson CM, Murray JB, Moore JD Bioorg Med Chem Lett. 2010 Nov 15;20(22):6483-8. Epub 2010 Sep 17. PMID:20932746<ref>PMID:20932746</ref> | |
| - | + | ||
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | + | </div> | |
| - | + | == References == | |
| - | == | + | <references/> |
| - | + | __TOC__ | |
| + | </StructureSection> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Peptidylprolyl isomerase]] | [[Category: Peptidylprolyl isomerase]] | ||
| - | [[Category: Baker, L | + | [[Category: Baker, L]] |
| - | [[Category: Bryant, C J | + | [[Category: Bryant, C J]] |
| - | [[Category: Davis, B E | + | [[Category: Davis, B E]] |
| - | [[Category: Dokurno, P | + | [[Category: Dokurno, P]] |
| - | [[Category: Fromont, C | + | [[Category: Fromont, C]] |
| - | [[Category: Matossova, N | + | [[Category: Matossova, N]] |
| - | [[Category: Moore, J D | + | [[Category: Moore, J D]] |
| - | [[Category: Murray, J B | + | [[Category: Murray, J B]] |
| - | [[Category: Northfield, C J | + | [[Category: Northfield, C J]] |
| - | [[Category: Nunns, C | + | [[Category: Nunns, C]] |
| - | [[Category: Oldfield, V | + | [[Category: Oldfield, V]] |
| - | [[Category: Potter, A | + | [[Category: Potter, A]] |
| - | [[Category: Ray, S | + | [[Category: Ray, S]] |
| - | [[Category: Richardson, C M | + | [[Category: Richardson, C M]] |
| - | [[Category: Robinson, D | + | [[Category: Robinson, D]] |
| - | [[Category: Scrace, S F | + | [[Category: Scrace, S F]] |
| - | [[Category: Surgenor, A E | + | [[Category: Surgenor, A E]] |
[[Category: Cell cycle]] | [[Category: Cell cycle]] | ||
[[Category: Isomerase]] | [[Category: Isomerase]] | ||
Revision as of 06:45, 19 December 2014
Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution
| |||||||||||
Categories: Homo sapiens | Peptidylprolyl isomerase | Baker, L | Bryant, C J | Davis, B E | Dokurno, P | Fromont, C | Matossova, N | Moore, J D | Murray, J B | Northfield, C J | Nunns, C | Oldfield, V | Potter, A | Ray, S | Richardson, C M | Robinson, D | Scrace, S F | Surgenor, A E | Cell cycle | Isomerase | Nucleus | Oncogenic transformation | Phosphoprotein | Ppiase | Proline directed kinase | Rotamase | Sbdd | Small molecule
